account_num,net_change,tag,tag_depth,cik
144,10491700000.0,CostOfRevenue,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
456,259300000.0,DepreciationAndAmortization,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
581,530800000.0,OperatingCostsAndExpenses,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2004,-25300000.0,OtherNonoperatingIncomeExpense,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1478,-5400000.0,IncomeLossFromEquityMethodInvestments,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1133,271500000.0,RestructuringSettlementAndImpairmentProvisions,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2710,-582100000.0,DeferredRevenueCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1025,259300000.0,AmortizationOfIntangibleAssets,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
845,259300000.0,AmortizationOfDeferredCharges,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
802,271500000.0,AssetImpairmentCharges,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
825,271500000.0,GoodwillAndIntangibleAssetImpairment,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3809,-493200000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2431,1500000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
3733,-26800000.0,AdditionalPaidInCapitalCommonStock,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2552,-1068800000.0,AccruedLiabilitiesCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1901,7600000.0,DeferredIncomeTaxAssetsNet,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1848,65700000.0,LongTermInvestmentsAndReceivablesNet,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1626,65700000.0,LongTermInvestments,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1557,65700000.0,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures,6,920148_LABORATORY CORP OF AMERICA HOLDINGS
2903,-1279100000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2590,-1279100000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1912,-1279100000.0,NetIncomeLoss,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1077,-1280600000.0,ProfitLoss,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3494,-422800000.0,OtherLiabilitiesNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1820,-2295800000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2399,302000000.0,IncomeTaxExpenseBenefit,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2149,-1988400000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3796,-1102500000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3379,-679700000.0,OperatingLeaseLiabilityNoncurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3303,-5122400000.0,LongTermDebtAndCapitalLeaseObligations,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3378,-83600000.0,FinanceLeaseLiabilityNoncurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3308,-5038800000.0,LongTermDebtNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3154,-3078500000.0,LiabilitiesCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2638,-6000000.0,DebtCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2737,-6000000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2809,-6000000.0,FinanceLeaseLiabilityCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2347,-2003600000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2398,-934800000.0,AccountsPayableCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2089,20155100000.0,Assets,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2091,15530100000.0,AssetsNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2041,432700000.0,OtherAssetsNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3645,-6224900000.0,LiabilitiesNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1827,12067900000.0,IntangibleAssetsNetIncludingGoodwill,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1711,8121000000.0,Goodwill,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1368,2956200000.0,PropertyPlantAndEquipmentNet,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
868,4625000000.0,AssetsCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
677,707000000.0,PrepaidExpenseCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
260,470600000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
455,470600000.0,InventoryNet,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
320,2222000000.0,ReceivablesNetCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
207,2222000000.0,AccountsNotesAndLoansReceivableNetCurrent,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
229,2222000000.0,AccountsReceivableNetCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
577,430000000.0,CashCashEquivalentsAndShortTermInvestments,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
645,430000000.0,CashAndCashEquivalentsAtCarryingValue,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1732,3946900000.0,IntangibleAssetsNetExcludingGoodwill,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3465,-10039600000.0,Liabilities,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
3661,-8100000.0,CommonStockValue,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3750,-26800000.0,AdditionalPaidInCapital,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1854,180300000.0,InterestAndDebtExpense,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1709,180300000.0,InterestExpense,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2130,-34200000.0,NonoperatingIncomeExpense,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1205,-8900000.0,InvestmentIncomeNonoperating,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3834,-10581700000.0,RetainedEarningsAccumulatedDeficit,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
3316,-10096600000.0,StockholdersEquity,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
3260,-10096600000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3917,-20155100000.0,LiabilitiesAndStockholdersEquity,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
173,-14876800000.0,Revenues,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
232,-4385100000.0,GrossProfit,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2257,-1993800000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
601,1996600000.0,SellingGeneralAndAdministrativeExpense,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1264,-1773900000.0,OperatingIncomeLoss,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1665,-8900000.0,InvestmentIncomeNet,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1112,2527400000.0,OperatingExpenses,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
